These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 2910589
1. Pathways of kinin formation and role in allergic diseases. Kaplan AP, Silverberg M, Ghebrehiwet B, Atkins P, Zweiman B. Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S41-51. PubMed ID: 2910589 [Abstract] [Full Text] [Related]
2. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Kaplan AP, Joseph K. Adv Immunol; 2014 Jan; 121():41-89. PubMed ID: 24388213 [Abstract] [Full Text] [Related]
5. Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. Atkins PC, Miragliotta G, Talbot SF, Zweiman B, Kaplan AP. J Immunol; 1987 Oct 15; 139(8):2744-8. PubMed ID: 3655370 [Abstract] [Full Text] [Related]
6. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Kaplan AP, Gruber B, Harpel PC. Blood; 1985 Sep 15; 66(3):636-41. PubMed ID: 3875374 [Abstract] [Full Text] [Related]
7. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Kaplan AP, Ghebrehiwet B, Silverberg M, Sealey JE. Crit Rev Immunol; 1981 Sep 15; 3(1):75-93. PubMed ID: 7047077 [Abstract] [Full Text] [Related]
8. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Kaplan AP, Joseph K. Clin Rev Allergy Immunol; 2016 Oct 15; 51(2):207-15. PubMed ID: 27273087 [Abstract] [Full Text] [Related]
9. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema. Madsen DE, Sidelmann JJ, Biltoft D, Gram J, Hansen S. Biochim Biophys Acta; 2015 Jun 15; 1850(6):1336-42. PubMed ID: 25800206 [Abstract] [Full Text] [Related]
10. The plasma bradykinin-forming pathways and its interrelationships with complement. Kaplan AP, Ghebrehiwet B. Mol Immunol; 2010 Aug 15; 47(13):2161-9. PubMed ID: 20580091 [Abstract] [Full Text] [Related]
11. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. Lewin MF, Kaplan AP, Harpel PC. J Biol Chem; 1983 May 25; 258(10):6415-21. PubMed ID: 6343376 [Abstract] [Full Text] [Related]
12. The bradykinin-forming cascade and its role in hereditary angioedema. Kaplan AP, Joseph K. Ann Allergy Asthma Immunol; 2010 Mar 25; 104(3):193-204. PubMed ID: 20377108 [Abstract] [Full Text] [Related]
14. Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa). Donaldson VH, Mitchell BH, Everson B, Ratnoff OD. Blood; 1990 Feb 15; 75(4):911-21. PubMed ID: 2302459 [Abstract] [Full Text] [Related]
15. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS, Gallin JI, Kaplan AP. J Clin Invest; 1974 Feb 15; 53(2):622-33. PubMed ID: 11344577 [Abstract] [Full Text] [Related]
16. [Immunologic abnormalities and the kallikrein-kinin system]. Yano S, Fujii T, Asanuma Y. Nihon Rinsho; 1978 Aug 15; 36(8):2922-6. PubMed ID: 362010 [No Abstract] [Full Text] [Related]